EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGE

被引：19

作者：

Bruix, J. ^{[1
]}

Raoul, J. L. ^{[2
]}

Sherman, M. ^{[3
]}

Shan, M. ^{[4
]}

Lentini, G. ^{[5
]}

Nadel, A. ^{[4
]}

Voliotis, D. ^{[4
]}

Llovet, J. M. ^{[1
,6
]}

机构：

[1] Hosp Clin Barcelona, IDIBAPS, CIBERehd, Liver Unit,Barcelona Clin Liver Canc BCLC Grp, Barcelona, Spain

[2] Ctr Eugene Marquis, Rennes, France

[3] Toronto Gen Hosp, Toronto, ON, Canada

[4] Bayer HealthCare Pharmaceut, Montville, NJ USA

[5] Bayer Schering Pharma, Wuppertal, Germany

[6] Mt Sinai Sch Med, Mt Sinai Liver Canc Program, New York, NY USA

来源：

关键词：

D O I：

10.1016/S0168-8278(09)60069-6

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S28 / S29

页数：2